Cerus Corp (NASDAQ: CERS) on Friday, plunged -4.44% from the previous trading day, before settling in for the closing price of $1.80. Within the past 52 weeks, CERS’s price has moved between $1.38 and $2.59.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 16.80%. The company achieved an average annual earnings per share of 45.71%. With a float of $176.34 million, this company’s outstanding shares have now reached $181.25 million.
Let’s determine the extent of company efficiency that accounts for 288 employees. In terms of profitability, gross margin is 55.3%, operating margin of -16.37%, and the pretax margin is -11.13%.
Cerus Corp (CERS) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Cerus Corp is 5.05%, while institutional ownership is 79.26%. The most recent insider transaction that took place on Sep 04 ’24, was worth 116,826. In this transaction Chief Financial Officer of this company sold 54,272 shares at a rate of $2.15, taking the stock ownership to the 536,093 shares. Before that another transaction happened on Sep 03 ’24, when Company’s Chief Financial Officer sold 28,385 for $2.18, making the entire transaction worth $61,919. This insider now owns 590,365 shares in total.
Cerus Corp (CERS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 45.71% per share during the next fiscal year.
Cerus Corp (NASDAQ: CERS) Trading Performance Indicators
Cerus Corp (CERS) is currently performing well based on its current performance indicators. A quick ratio of 1.92 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.11, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.08 in one year’s time.
Technical Analysis of Cerus Corp (CERS)
Looking closely at Cerus Corp (NASDAQ: CERS), its last 5-days average volume was 1.57 million, which is a jump from its year-to-date volume of 1.3 million. As of the previous 9 days, the stock’s Stochastic %D was 53.59%. Additionally, its Average True Range was 0.13.
During the past 100 days, Cerus Corp’s (CERS) raw stochastic average was set at 29.61%, which indicates a significant decrease from 39.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.29% in the past 14 days, which was higher than the 76.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7812, while its 200-day Moving Average is $1.9431. However, in the short run, Cerus Corp’s stock first resistance to watch stands at $1.7967. Second resistance stands at $1.8735. The third major resistance level sits at $1.9269. If the price goes on to break the first support level at $1.6665, it is likely to go to the next support level at $1.6131. Should the price break the second support level, the third support level stands at $1.5363.
Cerus Corp (NASDAQ: CERS) Key Stats
Market capitalization of the company is 305.23 million based on 185,715K outstanding shares. Right now, sales total 186,800 K and income totals -37,490 K. The company made 50,660 K in profit during its latest quarter, and -2,930 K in sales during its previous quarter.
